Date | Title | Description | Source |
29.04.2022 | Publication of Annual Report and Financial Statements for th... | This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regu... | globenewsw... |
30.03.2022 | Acacia Pharma to Postpone Publication of its Results for the... | THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION
Not for release, publication or distribution, in w... | globenewsw... |
23.03.2022 | Acacia Pharma Announces Chief Financial Officer Gary Gemigna... | This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regu... | globenewsw... |
15.03.2022 | Issue of Shares to Employee Benefit Trust | This announcement contains regulated information for the purposes of Article 7 of the Market Abuse R... | globenewsw... |
21.12.2021 | Acacia Pharma Issues Ordinary Shares to its Employee Benefit... | THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION.
Publication in application of Article 15 of the L... | globenewsw... |
16.12.2021 | Correction: Issue of Shares to Employee Benefit Trust | Correction – Admission Date for New Ordinary Shares Included
This announcement contains inside info... | globenewsw... |
16.12.2021 | Correction: Issue of Shares to Employee Benefit Trust | Correction – Admission Date for New Ordinary Shares Included
This announcement contains inside info... | marketscre... |
16.12.2021 | Issue of Shares to Employee Benefit Trust | This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regu... | globenewsw... |
13.12.2021 | Acacia Pharma Announces Successful Completion of BARHEMSYS® ... | This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regu... | marketscre... |
13.12.2021 | Acacia Pharma Announces Successful Completion of BARHEMSYS® ... | This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regu... | globenewsw... |
10.11.2021 | Acacia Pharma to Present at the Jefferies London Healthcare ... | Cambridge, UK and Indianapolis, US – 10 November 2021: Acacia Pharma Group plc (“Acacia Pharma”, the... | globenewsw... |
30.09.2021 | Acacia Pharma : Interim Results for the Six Months ended 30 ... | This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regu... | marketscre... |
30.09.2021 | Acacia Pharma : Mid-Year Presentation of Results for the Six... | Acacia Pharma Group plc
2021 Mid-Year Results Presentation September 30, 2021
Transforming Medicin... | marketscre... |
23.09.2021 | Acacia Pharma : to Report its Interim Results for the Six Mo... | 23 September 2021 Acacia Pharma to Report its Interim Results for the Six Months ended 30 June 2021 ... | marketscre... |
23.09.2021 | Correction: Notice of Results | Correction for date of KOL webcast
Acacia Pharma to Report its Interim Results for the Six Months e... | marketscre... |
01.07.2021 | Acacia Pharma : Announces Significant Continued Progress wit... | 01 July 2021 Acacia Pharma Announces Significant Continued Progress with Formulary Uptake of BARHEMS... | marketscre... |
04.05.2021 | ACACIA PHARMA GROUP PLC
Acacia Pharma : Announces Early Rep... | 04 May 2021 Acacia Pharma Announces Early Repayment of Loan Facility from Hercules Technology Growth... | marketscre... |
30.03.2021 | Acacia Pharma : Annual Report and Financial Statements for t... | Acacia Pharma Group plc Annual Report and Financial Statements
for the year ended 31 December 2020
... | marketscre... |
30.03.2021 | ACACIA PHARMA GROUP PLC
Acacia Pharma : Publication of Annu... | 30 March 2021 Publication of Annual Report and Financial Statements for the Year ended 31 December 2... | marketscre... |
30.03.2021 | ACACIA PHARMA GROUP PLC
Acacia Pharma : Annual Report and F... | Acacia Pharma Group plc Annual Report and Financial Statements
for the year ended 31 December 2020
... | marketscre... |
26.02.2021 | Issue of Equity on Exercise of Options/Vesting of Performanc... | Acacia Pharma Group plc
Issue of Equity on Exercise of Options/Vesting of Performance Share Awards
... | globenewsw... |
19.02.2021 | Acacia Pharma (EURONEXT: ACPH) raises EUR 27 million for US ... | Cambridge, UK and Indianapolis, US – Acacia Pharma (EURONEXT: ACPH), a commercial stage biopharmaceu... | gildehealt... |
19.02.2021 | Results of Placing – EUR 27 million Raised to Invest Further... | THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION. THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS D... | globenewsw... |
19.02.2021 | Acacia Pharma : Results of Placing – EUR 27 million Raised t... | THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION. THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS D... | marketscre... |
19.02.2021 | ACACIA PHARMA GROUP
Acacia Pharma : Results of Placing – EU... | THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION. THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS D... | marketscre... |
18.02.2021 | Change of EU home Member State | THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION
Acacia Pharma Group plc
Change of EU home Member ... | globenewsw... |
18.02.2021 | Proposed Capital Raising by way of a Placing of New Ordinary... | THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION. THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS D... | globenewsw... |
18.02.2021 | ACACIA PHARMA GROUP
Acacia Pharma : Proposed Capital Raisin... | THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION. THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS D... | marketscre... |
18.02.2021 | Acacia Pharma : Proposed Capital Raising by way of a Placing... | THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION. THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS D... | marketscre... |
12.02.2021 | Issue of Equity on Exercise of Options/Vesting of Performanc... | Acacia Pharma Group plc
Issue of Equity on Exercise of Options/Vesting of Performance Share Awards
... | globenewsw... |
12.10.2020 | COSMO PHARMACEUTICALS N.V.
Cosmo Pharmaceuticals N : Acacia... | Cambridge - Acacia Pharma Group plc ('Acacia Pharma', the 'Group' or the 'Company') (EURONEXT: ACPH)... | marketscre... |
09.10.2020 | ACACIA PHARMA GROUP
Acacia Pharma : completes drawdown from... | Acacia Pharma completes drawdown from €25 million loan facility from Cosmo Pharmaceuticals to suppor... | marketscre... |
14.08.2020 | Acacia Pharma raises €25M to launch BARHEMSYS® and BYFAVO™ i... | Cambridge (UK) and Indianapolis (US) – Acacia Pharma (EURONEXT: ACPH), a commercial stage biopharmac... | gildehealt... |
27.02.2020 | Acacia Pharma's twice spurned drug finally makes the FDA... | Third time’s the charm for Acacia Pharma.
The Cambridge, UK-based company on Thursday final... | endpts.com... |
03.05.2019 | FDA rejects Acacia's lead drug — again — due to the same ... | Acacia Pharma did well on the R&D front — by 2017, it had conducted four positive pivotal... | endpts.com... |
02.07.2018 | Acacia Pharma secures $30 million debt finance to support in... | Cambridge, UK and Indianapolis, US - Acacia Pharma (EURONEXT: ACPH), a hospital pharmaceutical compa... | gildehealt... |
02.03.2018 | Acacia Pharma Group raises €40m at IPO for US growth | - | fprimecapi... |
04.09.2013 | Acacia Pharma Raises £15M in Series B Financing | Acacia Pharma, a Cambridge, UK-based pharmaceutical company specializing in the development of drugs... | finsmes.co... |
03.09.2013 | Acacia Pharma Announces £15M ($23.5M) Series B Financing | Cambridge, UK – Acacia Pharma, the pharmaceutical company specialising in the development of drugs f... | gildehealt... |
03.09.2013 | Acacia Pharma Raises $23.5M |
CAMBRIDGE, ENGLAND, Pharmaceutical company specializing in the development of drugs for supportive... | vcnewsdail... |
31.03.2011 | Acacia Pharma Closes $10M Series A Funding Round | Acacia Pharma, a Cambridge, UK-based pharmaceutical company specializing in the development of drugs... | finsmes.co... |
31.03.2011 | Acacia Pharma Closes $10 Million Investment Round | Cambridge, UK – Acacia Pharma, a pharmaceutical company specialising in the development of drugs for... | gildehealt... |